These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. ACTH therapy in infantile spasms: side effects. Riikonen R; Donner M Arch Dis Child; 1980 Sep; 55(9):664-72. PubMed ID: 6254450 [TBL] [Abstract][Full Text] [Related]
63. Disturbed calcium and phosphate homeostasis during treatment with ACTH of infantile spasms. Riikonen R; Simell O; Jääskeläinen J; Rapola J; Perheentupa J Arch Dis Child; 1986 Jul; 61(7):671-6. PubMed ID: 3017235 [TBL] [Abstract][Full Text] [Related]
64. [Metabolic disorders induced by a combination of sodium gamma-hydroxybutyrate and tetracosactide in head-injury patients]. Béal JL; Freysz M; Honnart D; Wilkening M Therapie; 1983; 38(5):569-71. PubMed ID: 6322376 [No Abstract] [Full Text] [Related]
65. [Tetracosactide in the treatment of rheumatoid arthritis and gout]. Usobiaga JL Rev Esp Reum Enferm Osteoartic; 1975; 18(2):145-54. PubMed ID: 167406 [No Abstract] [Full Text] [Related]
66. [Hypersensitivity to tetracosactide]. Ligumski M; Kletter-Chemo D; Penchas S Harefuah; 1977 Feb; 92(4):169-70. PubMed ID: 191336 [No Abstract] [Full Text] [Related]
67. [Adverse effects of synthetic ACTH (tetracosactide-Zn)--asthmatic attack and shock-report of 2 cases]. Kawai M; Maekawa N Nihon Kyobu Shikkan Gakkai Zasshi; 1975 Nov; 13(11):663-70. PubMed ID: 176495 [No Abstract] [Full Text] [Related]
68. [Spastic flexion disorders: clinical and metabolic problems observed during treatment with zinc tetracosactide]. Cret L; David M; Macabéo V; Frédérich A; Jeune M Pediatrie; 1976; 31(1):33-48. PubMed ID: 184427 [No Abstract] [Full Text] [Related]